Intervention for Alcohol Use Disorder Recovery After Liver Transplantation (NCT07214259) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Intervention for Alcohol Use Disorder Recovery After Liver Transplantation
United States40 participantsStarted 2026-07
Plain-language summary
The goal of this clinical trial is to learn if it is feasible and acceptable to use a recovery coach and an online sober active community to help with alcohol use disorder after liver transplant. The main questions it aims to answer are:
* Is using a recovery coach after liver transplant to help with alcohol use recovery feasible and acceptable?
* Is using an online sober active community after liver transplant to help with alcohol use recovery feasible and acceptable? Researchers will compare standard of care including a recovery coach alone to a recovery coach plus to assist with recovery from alcohol use recovery after liver transplant
Participants will:
* Work with a recovery coach including a weekly phone call
* Visit the clinic once every 3 months for a checkup and to complete surveys
* If randomized to the intervention arm, download an online application with access to a digital sober active community
Who can participate
Age range
21 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria for Enrollment:
* Age greater than or equal to 21 years old
* Recipient of liver transplant less than or equal to 5 years ago
* History of alcohol use disorder
* Able to understand the purpose of the study and willing to participate and sign informed consent
* Has a smart phone to use for contact with recovery coach and the digital sober active community without additional personal cost
* Willing to participate in online digital community
Exclusion Criteria for Enrollment
* Liver transplant recipient for reason other than alcohol associated liver disease
* Liver transplant greater than 5 years ago
* No mechanism for regular phone contact
* No ability to utilize an application for a digital sober active community
* Any condition that in the opinion of the PI introduces undue risk by participating in this study
* less than 21 years of age
* no history of alcohol use disorder
* Any condition that in the opinion of the PI introduces undue risk by participating in this study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Acceptability of ILTARP (The perception that ILTARP is palatable, agreeable, or satisfactory)
Timeframe: Baseline, month 3, month 6, month 9, and study end (1 year)
2
Feasibility of ILTARP (the degree to which ILTARP can be carried out successfully)
Timeframe: Baseline, month 3, month 6, month 9, and study end (1 year)
3
Appropriateness of ILTARP (ILTARP suitability and relevance)
Timeframe: Baseline, month 3, month 6, month 9, and study end (1 year)